Group IVE sPLA2 activators represent a chemical class that targets a specific enzyme known as secretory phospholipase A2 group IVE (sPLA2 IVE). This enzyme is part of a larger family of lipolytic enzymes, which are involved in the hydrolysis of phospholipids, leading to the release of fatty acids and lysophospholipids. The group IVE sPLA2 activators specifically interact with the IVE isoform of sPLA2, which possesses a unique structure and catalytic mechanism compared to other members of the sPLA2 family. The structure of sPLA2 IVE includes a conserved calcium-binding loop and a heparin-binding domain, which are crucial for its enzymatic function and interaction with cellular membranes.
The design and development of group IVE sPLA2 activators are based on understanding the enzyme's active site and the key residues involved in substrate binding and catalysis. These activators modulate the enzyme activity by binding to it in a manner that enhances its interaction with the phospholipid substrates. The activation of sPLA2 IVE leads to an increased catalytic turnover of membrane phospholipids, which is a fundamental biochemical process in cellular physiology. The specific mechanism by which these activators enhance sPLA2 IVE activity can vary, but it typically involves an allosteric effect or direct binding to the catalytic site that augments substrate affinity or catalytic efficiency. The study of these activators contributes to a deeper understanding of lipid metabolism and enzyme regulation at the molecular level, shedding light on the intricate processes that govern cellular homeostasis and the dynamics of lipid-rich cellular membranes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
As a substrate for the group IVE sPLA2 enzyme, arachidonic acid availability can enhance the activity of group IVE sPLA2 by providing more of the lipid molecules that group IVE sPLA2 acts upon, leading to increased production of eicosanoids, which are involved in signaling pathways such as inflammation. | ||||||
MAFP | 188404-10-6 | sc-203440 | 5 mg | $219.00 | 4 | |
This specific inhibitor of cytosolic PLA2 can paradoxically lead to the compensatory upregulation and activation of group IVE sPLA2 by reducing competition for common substrates, thereby allowing group IVE sPLA2 to have increased access to arachidonic acid-containing phospholipids. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 can indirectly enhance the activity of group IVE sPLA2 via the feedback upregulation of the enzyme due to its role in inflammatory signaling pathways where group IVE sPLA2 is involved in the production of inflammatory mediators. | ||||||
LTB4 (Leukotriene B4) | 71160-24-2 | sc-201043 | 50 µg | $374.00 | 4 | |
Leukotriene B4 can enhance the activity of group IVE sPLA2 by potentiating inflammatory signaling pathways where group IVE sPLA2 plays a crucial role in biosynthesizing lipid mediators like LTB4 itself. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
As group IVE sPLA2 requires calcium for its activity, the calcium ionophore A23187 can increase intracellular calcium levels and thereby directly enhance the enzymatic activity of group IVE sPLA2. | ||||||